Entry Detail



General Information

Database ID:exR0226527
RNA Name:hsa-miR-671-5p
RNA Type:miRNA
Chromosome:chr7
Starnd:+
Coordinate:
Start Site(bp):151238449End Site(bp):151238471
External Links:hsa-miR-671-5p



Disease Information

Disease Name:Latent Tuberculosis
Disease Category:Infections
MeSH ID:D055985
Type:Diseases Category/Infections
Alias:Latent Tuberculoses//Tuberculoses, Latent//Tuberculosis, Latent//Latent Tuberculosis Infection//Infection, Latent Tuberculosis//Infections, Latent Tuberculosis//Latent Tuberculosis Infections//Tuberculosis Infection, Latent//Tuberculosis Infections, Latent



Expression Detail

GEO ID:GSE124120
Description:Small RNA Profiles of Serum Exosomes Derived from Individuals with Latent and Active Tuberculosis
Experimental Design:Disease vs Control
Case Disease Type:Active Tuberculosis
Case Disease SubType:NA
Case Sample:Latent Tuberculosis
Control Sample:Healthy
Number of Case:1
Number of Control:1
Number of Samples:2





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
RCOR1
chr14
102592649
102730561
+
KIAA0232
chr4
6781375
6884170
+
TAF8
chr6
42050513
42087461
+
MAFG
chr17
81918270
81927735
-
DYRK1A
chr21
37365573
37526358
+
MED22
chr9
133338312
133348131
-
KLC1
chr14
103561896
103714249
+
CBX6
chr22
38861422
38872249
-
SAMD4B
chr19
39342396
39385710
+
GTSE1
chr22
46296870
46330810
+
SETD5
chr3
9397615
9479240
+
CREG1
chr1
167529117
167553805
-
IRS2
chr13
109752695
109786583
-
SCAMP3
chr1
155255979
155262430
-
CCDC6
chr10
59788747
59906556
-
BAZ2A
chr12
56595596
56636816
-
WDR82
chr3
52254434
52288020
-
TOMM6
chr6
41787662
41789898
+
FAM219A
chr9
34398184
34458570
-
STAT3
chr17
42313324
42388568
-
UHRF1BP1
chr6
34792015
34883138
+
AL365205.1
chr6
41780349
41790141
+
NACC1
chr19
13116862
13141147
+
SMAD3
chr15
67063763
67195169
+
WDTC1
chr1
27234632
27308636
+
IL1R1
chr2
102064544
102179874
+
PTPRU
chr1
29236516
29326813
+
GLYR1
chr16
4803203
4847288
-
APLP2
chr11
130068147
130144811
+
CHTF8
chr16
69118010
69132578
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC067930.1
chr8
143579636
143580670
+
AC145207.5
chr17
81878425
81881106
-
AL022311.1
chr22
37876148
37895563
+
AL137127.1
chr1
19072110
19075511
-
H19
chr11
1995176
2001470
-
KCNQ1OT1
chr11
2608328
2699994
-
LINC01278
chrX
63222993
63561095
-
MIR29B2CHG
chr1
207801518
207879115
-
NEAT1
chr11
65422774
65445540
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE124120
Sample Source:Blood
Source Fraction:Exosome
Platform:GPL16791
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:356
Sample treatment protocol:We first performed differential centrifugation (1000 g for 10 min at 4 °C, and 16,500 g for 30 min at 4 °C) to remove the cell debris, followed by ultrafiltration using 0.22 um filters. We then performed ultracentrifugation (120,000 g for 2 hours) to obtain exosome pellets. Transmission electron microscopy (TEM) was employed to visualize exosomes. The exosome pellets were first suspended and dropped onto 200 mesh copper grids, followed by incubation in 3% phosphotungstic acid for 10 min. The copper mesh was then washed three times with water and dried for observation by TEM. We also analyzed the exosome size distributions using the nanoparticle tracking analysis (NTA, Malvern, UK) according to the manufacturer's instructions.
RNA Extract protocol:NA
RNA library preparation protocol:Small RNA libraries were prepared for sequencing using standard Illumina protocols.



Reference

PMID:https://doi.org/10.3389/fmicb.2019.01174
Title:Small RNA Profiles of Serum Exosomes Derived From Individuals With Latent and Active Tuberculosis
Author:Lingna Lyu, Xiuli Zhang, Cuidan Li, Tingting Yang, Jinghui Wang, Liping Pan, Hongyan Jia, Zihui Li, Qi Sun, Liya Yue, Fei Chen and Zongde Zhang
Journal:Front. Microbiol., 28 May 2019 | https://doi.org/10.3389/fmicb.2019.01174
Description:In this study, we performed small RNA sequencing to explore small RNA profiles of serum exosomes derived from LTBI and TB patients and healthy controls (HC).